MER Primary Care Conferences Internal Medicine for Primary Care Cardio Mens Uro Pain Risk Mgmt June 7 – 11, 2026

• Include:  videos +  file sub vtt, size:  GB
• Target Audience: primary care physicians
• Sample video: contact me for sample video
• Information:

INTERNAL MEDICINE FOR PRIMARY CARE: CARDIOLOGY/MEN’S UROLOGY/PAIN/RISK MANAGEMENT

Walt Disney World® Resort, FL – Disney’s Yacht & Beach Club Resorts

Target Audience

This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine

Learning Objectives

Upon completion of this program, participants should be better able to:

Describe current diagnostic approaches and the role of drug therapy to the patient with acute chestpain

Implement lifestyle changes as well as lipid and cholesterol guidelines for the prevention of CAD- Implement treatment strategies reflective of recent guidelines and current evidence based medicine for heart failure

Explain current concepts in the diagnosis and treatment of hypertension

Describe current diagnostic and treatment approaches to arrhythmias and atrial fibrilation

Design opioid pain management strategies

Design non-opioid pain management strategies

Discuss some of the controversies surrounding pain management

Compare the benefits and side effect profiles of pharmacologic treatment options for fibromyalgia- Describe how non-surgical activity modification and physical therapy can benefit low back pain patients

Discuss medical management of male sexual health

Discuss the biology, screening, and treatment options of prostate cancer

Evaluate and manage sexually-transmitted infections in men

Differentiate between benign prostate conditions and prostate cancers

Discuss the biology and screening, and treatment options of prostate and testicular cancer

Develop strategies for mitigating risky malpractice situations in practice

Describe how informed consent and shared decision making reduces risk for the provider

Identify adequate documentation samples that reduce risk to the provider – Examine the roles of cognitive biases, communication breakdowns, and system pressures in contributing to medical gaslighting experiences

Describe strategies to incorporate AI tools to improve patient outcomes

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Orlando, FL – June 7, 2026 (Day 1).mp4

Orlando, FL – June 8, 2026 (Day 2).mp4

Orlando, FL – June 9, 2026 (Day 3).mp4

Orlando, FL – June 10, 2026 (Day 4).mp4

Orlando, FL – June 11, 2026 (Day 5).mp4

* Detail:

Sunday, June 7, 2026

2:30 pm Check-In

Diagnosis and initial evaluation in the primary care setting, urgent care clinic and emergency department; Initial workup, treatment, and follow-up; Diagnosing and treating ST segment elevation and non-ST segment elevation MIs; The role of drug therapy–primary vs adjunctive to PCI; Follow up after acute coronary syndromome

Definitions; AHA/ACC and other lipid guidelines updates; HDL Cholesterol: The good cholesterol?; Metabolic syndrome and/or obesity; Who needs treatment and how much; The role of lifestyle changes, exercise and cardiac rehabilitation; Drug therapy updates; Risk calculation

Etiologies and stages of heart failure; ACC/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices in treatment and antiplatelet drugs; Issues related to the hospitalized patient with acute decompensated heart failure and readmissions

6:00 pm Session Adjourns

Monday, June 8, 2026

7:00 am Arrival and Breakfast

Overall safety and efficacy; Selecting and monitoring patients; Pain contracts; Regulatory issues; Urine drug testing

NSAID’s; Acetaminophen; Topicals; Injections; Antidepressants; Anticonvulsants; Medical marijuana

Urine drug testing, cannabinoids

The 2017 AHA/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; Treating special populations: diabetics, the elderly, patients with renal failure

Types and symptoms of arrhythmias; Approach to the patient: when to treat, when to refer, when to admit; Evaluation of the patient with palpitations; Atrial fibrilation: the use of anticoagulants indications, CVA risk scores, warfarin vs newer oral anticoagulants, controlling heart rate vs rhythm; Ventricular and other arrhythmias: when are they serious

12:40 pm Session Adjourns

Tuesday, June 9, 2026

7:00 am Arrival and Breakfast

Treatment algorithm and safety profiles for the treatment of erectile dysfunction; testosterone supplementation for the treatment of ED or hypogonadism

Presenting symptoms, lesions, latencies, diagnostic work-ups and therapies of the common sexually transmitted diseases

Differential diagnosis and treatment of this difficult-to-manage pain syndrome; Treatment options of anti-epileptics and SNRI’s

Comprehensive overview of various options for activity modification; The role and maximum benefit of physical therapy and the various modalities; Medications; Discussion of interventional treatments

12:40 pm Session Adjourns

Wednesday, June 10, 2026

7:00 am Arrival and Breakfast

The Anatomy of Medical Malpractice

Identify the key elements of a malpractice claim in the practice setting; Assess the risk of malpractice in common and unusual situations; Identify risk management strategies for preventing claims

Describe the necessary elements of an informed consent process; Discover why the shared decision making process represents and opportunity rather than an obligation for the provider; Discuss the importance of early disclosure of unanticipated outcomes; Learn methods to disclose and reconcile events with patients, families and providers

Articulate major patient safety and lawsuit risk areas abetted by the quality of documentation; Discuss what is considered adequate documentation in a given clinical encounter; Anticipate when more thorough documentation and direct communication with other providers may reduce adverse outcomes; Describe clinical situations where documentation may enhance shared decision making to improve patient safety

Appropriate primary medical management of lower urinary tract symptoms (LUTS) (also known as BPH) as well as identification of patients with complex or refractory cases that warrant referral; diagnosis and treatment of epididymitis, testicular pain, prostatitis and other benign findings

Biology and treatment options using current medical technology of prostate cancer; evaluation and treatment of testicular cancer and long-term ramifications after cure

12:40 pm Session Adjourns

Thursday, June 11, 2026

7:00 am Arrival and Breakfast

Medical gaslighting is recognized as a serious patient safety concern. The term describes situations in which a patient’s symptoms, concerns, or lived experience are minimized, dismissed, or misattributed by a clinician—often unintentionally. The impact can be significant: delays in diagnosis, erosion of trust, and preventable adverse outcomes. This discussion will explore how cognitive biases, communication breakdowns, and system pressures contribute to these experiences.

Artificial Intelligence is rapidly transforming medicine, from clinical decision support and imaging to communication, documentation, and administrative work flows.  AI-driven tools promise to enhance efficiency and patient outcomes, but they also introduce new challenges.  This session will explore how AI works, examine its clinical, social, and operational applications, and discuss the evolving legal and patient safety implications, including risks for medical liability.

9:30 am Conference Adjourns